semaj83/ctmatch_classification huggingface dataset:
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Hematologic Neoplasm Acute Leukemia Myelodysplastic Syndrome Lymphoma, Multiple Myeloma Potential subjects must satisfy all of the following to be enrolled in the study diagnosis of hematologic neoplasm (acute leukemia, myelodysplastic syndrome, lymphoma, multiple myeloma, chronic myeloid leukemia, Ph-negative chronic myeloproliferative neoplasms) independently of the stage of disease or treatment (including transplant procedures) platelet count <50 x109/L at the time of starting antithrombotic prophylaxis or platelet count <50 x109/L at the time of diagnosis of arterial or venous thromboembolism objectively proven or platelet count >50 x109/L at time of thrombosis but subsequent thrombocytopenia <50 x109/L while receiving antithrombotic treatment diagnosis of arterial thrombosis acute coronary syndrome, ischemic stroke (including major and minor stroke), peripheral arterial thrombosis, retinal arterial thrombosis diagnosis of venous thrombosis thrombosis of deep veins of the limbs and the abdomen, superficial veins of limbs, cerebral and splanchnic veins, retinal vein, and pulmonary embolism. Splanchnic venous thrombosis occlusion of hepatic, portal, mesenteric, and splenic veins  The following situations will not be of neither outcomes of interest transient ischemic attack without CT and/or NMR signs superficial vein thrombosis without Doppler ultrasound examination showing evidence of thrombosis antithrombotic prophylaxis only local for central venous lines (i.e. CVC flushing with heparin) occlusion of the central venous catheter (notice that CVC-related deep venous thrombosis, i.e. thrombosis of the deep veins where the central line is placed, will be a criterion of or an outcome of antithrombotic prophylaxis)
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 40.0-90.0,  Diabetes Peripheral Arterial Disease Women Diagnosis of diabetes Diagnosis of peripheral arterial disease  Regular physical activity Smokers Thrombosis active Severe peripheral arterial disease
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 18.0-80.0,  Heart Failure Patients over 18 years of age with chronic heart failure, ischemic and non-ischemic etiology NYHA (New York Heart Association) class II-IV LVEF (Left Ventricular Ejection Fraction) ≤ 35% Patients treated with maximum tolerated doses of standard pharmacotherapy for heart failure, who were stable for at least four weeks without acute decompensated heart failure Prior to enrollment, patients must give informed consent  Patients with history of acute coronary syndrome or stroke within the last 6 months Significant valvular defects and/or planned cardiac surgery Systolic blood pressure <110 mmHg Advanced renal insufficiency (estimated GFR (Glomerular Filtration Rate) according to MDRD <30 ml/min/1.73 square meters) Unsuitable anatomy of renal arteries (presence of significant renal stenosis, renal artery narrower than 4 mm) Patients who underwent renal angioplasty or stent placement into the renal artery in the past Severe coagulation disorders Pregnancy or lactation Refusal of the patient Other diseases limiting prognosis of the patient to less than 2 years
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Percutaneous Closure of Arteriotomy in Common Femoral Artery Over 18 years of age Each patient, or his or her guardian or legal representative, is willing to give informed consent Clinically indicated for an endovascular procedure involving access through the femoral artery, with an access puncture of 18 Females who are not pregnant or lactating, and not planning to become pregnant ≤ 12 months. A pregnancy test may be performed to confirm this  There will be no of patients from this trial in respect of race, co-existent disease or concomitant therapy, with the exception of those listed below Severe acute non-cardiac systemic disease or terminal illness with a life expectancy of less than one year Evidence of systemic bacterial or cutaneous infection, including groin infection Evidence of MRSA (Methicillin-resistant Staphylococcus aureus) and/or VRE (vancomycin-resistant Enterococci) colonisation With arterial access other than the common femoral artery.* Patients suffering with definitive or potential coagulopathy or platelet count less than 100,000/µl Patient with a haematocrit of less than 32 % A measured activated clotting time (ACT) of greater than 350 seconds immediately prior to sheath removal.* If patients are expected to be continuously treated with anticoagulation therapy post-procedure such that their ACT reading is expected to be elevated above 350 seconds for more than 24 hours after the procedure Evidence of arterial diameter stenosis greater than 20 % within 20 mm of the arteriotomy.*
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 18.0-90.0,  Postcardiac Arrest Pulseless Electrical Activity Asystole Admission to adult ICU (age ≥18 years) at London Health Sciences Centre Primary reason for ICU admission: postcardiac arrest Both in-hospital and out-of-hospital cardiac arrest will be included ICU admission between Jan 2008 and Dec 2012  ICU admissions primarily for reasons other than cardiac arrest
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Vascular Access Complication Comfort CAG or PCI performed via the femoral artery No hematoma in the groin (> 5 cm in diameter) Heparin reversed with protamine after PCI  Oozing, bleeding or hematoma Treatment with Integrilin, ReoPro, or Marevan Heparin can not be reversed The patient does not want to participate Systolic blood pressure > 180 mm Hg after the procedure BMI> 35 (can be modified if the groin can be assessed in an upright position) Demented, unconscious patients who do not understand the information for participants
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Coronary Artery Disease patients of both sexes older than 18 years submitted to CABG with CPB, presence of coronary disease confirmed by coronary angiography, use of the left internal thoracic artery and/or saphena, patients who remained in spontaneous ventilation on the first postoperative day, absence of chronic or acute pulmonary disease, and giving written informed consent to participate in the study  intraoperative change of the surgical technique, surgical complications or complications occurring in the ICU, emergency reoperation, renal failure, failure to agree to continue in the study, presence of other types of heart disease, and presence of pulmonary diseases
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Abdominal Aortic Aneurysm Carotid Atherosclerosis Critical Lower Limb Ischaemia Age greater than 18 years Patient willing to give full informed consent for participation Patients undergoing elective carotid endarterectomy or Patients undergoing open abdominal aortic aneurysm repair or Patients undergoing endovascular abdominal aneurysm repair or Patients undergoing surgical lower limb revascularisation (suprainguinal or infrainguinal)  Pregnancy Significant upper limb peripheral arterial disease Previous history of upper limb deep vein thrombosis Patients on glibenclamide or nicorandil (these medications may interfere with RIPC) Patients with an estimated pre-operative glomerular filtration rate < 30mls/min/1.73m2 Patients with a known history of myocarditis, pericarditis or amyloidosis Patients with an estimated pre-operative glomerular filtration rate < 30mls/min/1.73m2 Patients with severe hepatic disease defined as an international normalised ratio >2 in the absence of systemic anticoagulation Patients with severe respiratory disease (for the trial, defined as patients requiring home oxygen therapy) Patients previously enrolled in the trial representing for a further procedure Patients with previous axillary surgery
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cardiovascular Disease eligible transplanted patients scheduled for a routine coronary angiography with age >18 years old  chronic renal insufficiency (creatinine >2.0 mg/dl) with the potential necessity of using the radial artery as a native fistula will be considered one of the criteria in case of an abnormal or doubtful bilateral Allen's test, a pletysmography will be done. The presence of a type A or B curve will be considered a marker of adequate hand collaterals and the procedure will be able by this access. Only the presence of bilateral type C or D curves will be considered a contraindication to trans radial approach
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Acute Coronary Syndromes Angioplasty, Transluminal, Percutaneous Coronary Unstable angina with an indication for invasive stratification Acute coronary syndrome without ST-segment elevation Acute coronary syndrome with ST-segment elevation Patient informed of the nature of the study and have signed the Informed Consent Patient suitable for coronary angiography and / or percutaneous coronary intervention either by radial access as the femoral  Below 18 years of age Pregnancy Chronic use of vitamin K antagonists, or direct thrombin inhibitors or antagonists of factor Xa Active bleeding or high risk of bleeding (severe hepatic insufficiency, active peptic ulcer disease, creatinine clearance <30 mL / min, platelet count <100,000 mm3) Uncontrolled hypertension Cardiogenic shock Previous coronary artery bypass graft surgery with the use of ≥ 1 graft Patients not candidates for the use of any of the specified vascular access Concomitant severe disease with life expectancy less than 12 months life Medical, geographical, or social conditions that impede study participation
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 18.0-80.0,  Hemorrhoids Pain, Postoperative Patients with symptomatic grade III or IV hemorrhoids (bleeding, pain, itching, soiling or prolapse) that are elegible for surgical treatment with both methods  Associated recto-anal pathology such as acute thrombosed hemorrhoid, anal fissure, perianal fistula, perianal abscess, rectal prolapse, fecal incontinence or anal stenosis Prior anorectal surgery  Systemic pathology that could alter the outcome of the surgery as coagulopathies, chronic pain with continued consumption of analgesics Age younger than 18 or older than 80 years, socio-pathology or inability to understand the study objectives
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Coronary Disease >18 year Should be able to provide valid informed signed consent CAG, possibly including intracoronary measurement (FFR) or intracoronary imaging (IVUS, optical coherence tomography (OCT), NIRS)  Percutaneous coronary intervention (PCI) procedure and/or implantation of stents ST-Elevations Myocardial Infarction (STEMI) Multiple punctures Active infection Groin haematoma before the closure procedure Known pseudoaneurysm or arteriovenous (AV) fistula in the ipsilateral groin Cardiogenic shock Prior peripheral arterial surgery in abdomen or lower extremities Sheat size >7 F Life expectancy less than one year
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Endovascular Procedure Requiring an Arteriotomy in the Range of 18 to 24 F, Via the Common Femoral Artery. Over 18 years of age Each patient, or his or her guardian or legal representative, is willing to give informed consent Clinically indicated for an endovascular procedure involving access through the femoral artery, with an access puncture of 18 French (F) Females who are not pregnant or lactating, and not planning to become pregnant in ≤ 12 months  Severe acute non-cardiac systemic disease or terminal illness with a life expectancy of less than one year Evidence of systemic bacterial or cutaneous infection Evidence of MRSA (Methicillin-resistant Staphylococcus aureus) and/or VRE (vancomycin-resistant Enterococci) colonisation Arterial access other than the common femoral artery Patients suffering with definitive or potential coagulopathy or platelet count less than 100,000/μl Patient with a haematocrit of less than 32 % A measured activated clotting time (ACT) of greater than 350 seconds immediately prior to sheath removal If patients are expected to be continuously treated with anticoagulation therapy post-procedure such that their ACT reading is expected to be elevated above 350 seconds for more than 24 hours after the procedure Evidence of arterial diameter stenosis greater than 20 % within 20 mm of the arteriotomy Circumferential calcification within 20 mm of the arteriotomy
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Renal Failure Chronic Requiring Hemodialysis Central Venous Catheterization Inadequate Hemodialysis Blood Flow Venous Stenosis Venous Thrombosis Infection Due to Central Venous Catheter Central Venous Catheter Thrombosis Chronic renal failure requiring hemodialysis No medical history of central vena catheterization Maintenance hemodialysis after central vena catheterization Signed informed consent  Had been performed central venous puncture or catheterization before Can not use heparin Refused to sign the informed consent Advanced cancer patients With or will take arteriovenous fistula surgery in right arm Other inappropriate situation
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 25.0-90.0,  Carotid Artery Thrombosis Carotid Artery Stenosis Stroke Carotid stenosis > 60%  Redo carotid surgery Radiation induced carotid stenosis Extensive carotid lesion > 5 cm in length with involvement of the common carotid artery best treated by a carotid bypass
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Peripheral Artery Disease Critical Limb Ischemia Claudication Age ≥ 18 Patient undergoing vascular surgery that would a groin incision as a standard part of the operation. Infrainguinal bypass including femoral popliteal/tibial/pedal artery bypass with autogenous or prosthetic conduit Willing to comply with protocol, attend follow-up appointments, complete all study assessments, and provide written informed consent  Any groin incision on index leg within 12 weeks prior to treatment initiation Infrainguinal bypass without a groin incision including popliteal-tibial or pedal bypass Supra inguinal procedures such as open or endovascular abdominal aortic aneurysm repair or aorto-femoral/bi-femoral bypass for occlusive disease Undergoing current chemotherapy or radiation therapy Pregnancy or lactation Inability or refusal to provide informed consent Patients who received an investigational drug for peripheral arterial disease within 4 weeks of screening or who participated in another non-observational clinical trial in the prior 30 days Surgical incision in the groin without primary closure including previously open or infected wounds Sensitivity or allergy to silver Prior enrollment in this randomized controlled trial
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 0.0-17.0,  Intraoperative Complications Postoperative Complications Surgical admission, with a noncardiac surgical interventions Aged between >28 days and <18years on the day of the surgical intervention  Non-surgical admission Surgical interventions with <10 per group Cardio-thoracic and interventional cardiology procedures
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  ATRIAL FLUTTER indication for atrial flutter ablation  history of recent femoral vein thrombosis (within last 6 months)
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 18.0-75.0,  Pain, Postoperative Total Knee Arthroplasty Able to consent to regional anesthesia and having primary total knee arthroplasty/replacement  Body-Mass Index >40 Iliac to Patella Distance (IPD) <40cm Pre-existing quadriceps weakness of involved surgical side Chronic opioid use (if using opioids within 4 weeks of surgery: excluded)
Patient description: A physician is called to see a 67-year-old woman who underwent cardiac catheterization via the right femoral artery earlier in the morning. She is now complaining of a cool right foot. Upon examination she has a pulsatile mass in her right groin with loss of distal pulses, and auscultation reveals a bruit over the point at which the right femoral artery was entered.

Clinical trial eligibility criteria: eligible ages (years): 18.0-75.0,  Vascular Fistula Age from 18 to 75 years Radial artery diameter <2.0 mm or cephalic vein diameter in the forearm <2.5 mm Brachial artery diameter ≥ 2 mm  Stenosis or thrombosis present in the draining vein A history of peripheral ischemia in upper extremities Active local or systemic infections Inability to consent for the procedure Patients with previous dysfunctional forearm fistula